Iwadate Y - Search Results

1

Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.

Kubota M, Yoshida Y, Kobayashi E, Matsutani T, Li SY, Zhang BS, Mine S, Machida T, Takizawa H, Hiwasa T, Iwadate Y. Kubota M, et al. Among authors: iwadate y. Sci Rep. 2021 Nov 5;11(1):21772. doi: 10.1038/s41598-021-01176-8. Sci Rep. 2021. PMID: 34741085 Free PMC article.

2

Paraganglioma in the frontal skull base--case report.

Yamauchi T, Kubota M, Saeki N, Aihara N, Iwadate Y, Yamaura A. Yamauchi T, et al. Among authors: iwadate y. Neurol Med Chir (Tokyo). 1999 Apr;39(4):308-12. doi: 10.2176/nmc.39.308. Neurol Med Chir (Tokyo). 1999. PMID: 10358987 Free article. Review.

3

Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.

Mochizuki S, Iwadate Y, Namba H, Yoshida Y, Yamaura A, Sakiyama S, Tagawa M. Mochizuki S, et al. Among authors: iwadate y. Int J Oncol. 1999 Nov;15(5):983-9. doi: 10.3892/ijo.15.5.983. Int J Oncol. 1999. PMID: 10536183

4

Hypervascular vestibular schwannomas.

Yamakami I, Kobayashi E, Iwadate Y, Saeki N, Yamaura A. Yamakami I, et al. Among authors: iwadate y. Surg Neurol. 2002 Feb;57(2):105-12. doi: 10.1016/s0090-3019(01)00664-4. Surg Neurol. 2002. PMID: 11904203

5

Acquisition of drug resistance by constitutive suppression of NF-kappaB in ras-transformed NIH3T3 mouse fibroblasts.

Sakaida T, Iwadate Y, Yamaji S, Uehara M, Noda A, Takiguchi M, Yamaura A, Hiwasa T. Sakaida T, et al. Among authors: iwadate y. Int J Oncol. 2003 Oct;23(4):1071-7. Int J Oncol. 2003. PMID: 12963987

6

Molecular classification and survival prediction in human gliomas based on proteome analysis.

Iwadate Y, Sakaida T, Hiwasa T, Nagai Y, Ishikura H, Takiguchi M, Yamaura A. Iwadate Y, et al. Cancer Res. 2004 Apr 1;64(7):2496-501. doi: 10.1158/0008-5472.can-03-1254. Cancer Res. 2004. PMID: 15059904

7

Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas.

Iwadate Y, Sakaida T, Saegusa T, Hiwasa T, Takiguchi M, Fujimoto S, Yamaura A. Iwadate Y, et al. Int J Oncol. 2005 Apr;26(4):993-8. Int J Oncol. 2005. PMID: 15753994

8

Cathepsin D is a potential serum marker for poor prognosis in glioma patients.

Fukuda ME, Iwadate Y, Machida T, Hiwasa T, Nimura Y, Nagai Y, Takiguchi M, Tanzawa H, Yamaura A, Seki N. Fukuda ME, et al. Among authors: iwadate y. Cancer Res. 2005 Jun 15;65(12):5190-4. doi: 10.1158/0008-5472.CAN-04-4134. Cancer Res. 2005. PMID: 15958563

9

High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas.

Iwadate Y, Hayama M, Adachi A, Matsutani T, Nagai Y, Hiwasa T, Saeki N. Iwadate Y, et al. Anticancer Res. 2008 Jan-Feb;28(1B):415-8. Anticancer Res. 2008. PMID: 18383878 Free article.

10

Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma.

Matsutani T, Nagai Y, Mine S, Murai H, Saeki N, Iwadate Y. Matsutani T, et al. Among authors: iwadate y. Acta Neurochir (Wien). 2009 Mar;151(3):263-8; discussion 268. doi: 10.1007/s00701-009-0199-3. Epub 2009 Feb 25. Acta Neurochir (Wien). 2009. PMID: 19240976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters